| External validation of diagnostic models to estimate the risk of malignancy in adnexal masses. | |
| | |
MedLine Citation:
|
PMID: 22114135 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AimTo externally validate and compare the performance of previously published diagnostic models developed to predict malignancy in adnexal masses.MethodsWe externally validated the diagnostic performance of 11 models developed by the International Ovarian Tumor Analysis (IOTA) group and 12 other (non-IOTA) models on 997 prospectively collected patients. The non-IOTA models included the original risk of malignancy index (RMI), three modified versions of the RMI, six logistic regression models and two artificial neural networks. The ability of the models to discriminate between benign and malignant adnexal masses was expressed as the area under the receiver operating characteristic curve (AUC), sensitivity, specificity and likelihood ratios (LR +, LR -). Results742 (74%) benign and 255 (26%) malignant masses were included. The IOTA models performed better than the non-IOTA models (AUCs between 0.941 and 0.956 versus 0.839 and 0.928). The difference in AUC between the best IOTA and the best non-IOTA model was 0.028 (95% CI, 0.011-0.044). The AUC of the Risk of Malignancy Index (RMI) was 0.911 (difference with the best IOTA model, 0.044; 95% CI, 0.024-0.064). The superior performance of the IOTA models was most pronounced in premenopausal patients but was also observed in postmenopausal patients. IOTA models were better able to detect stage I ovarian cancer.ConclusionExternal validation demonstrates that the IOTA models outperform other models -including the current reference test RMI - for discriminating between benign and malignant adnexal masses. |
| | |
Authors:
|
Caroline D Van Holsbeke; Ben Van Calster; Tom Bourne; Silvia Ajossa; Antonia C Testa; Stefano Guerriero; Robert Fruscio; Andrea A Lissoni; Artur Czekierdowski; Luca Savelli; Sabine Van Huffel; Lil Valentin; Dirk Timmerman |
Related Documents
:
|
23574215 - Pre-selective screening for matrix elements in linear-scaling exact exchange calculations. 22100905 - Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperpl... 7170025 - Physiological methods for assessment of trimethyltin exposure. 20300615 - Correction: towards a rigorous assessment of systems biology models: the dream3 challen... 21230565 - Simple predator-prey swarming model. 20438275 - Correction to klauer et al. (2010). |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-23 |
Journal Detail:
|
Title: Clinical cancer research : an official journal of the American Association for Cancer Research Volume: - ISSN: 1078-0432 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9502500 Medline TA: Clin Cancer Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Time-dependent changes in autonomic control of splanchnic vascular resistance and heart rate in ANG ...
Next Document: MicroRNA molecular profiles associated with diagnosis, clinicopathological criteria, and overall sur...